News

Asieris Pharmaceuticals to Participate at 2017 BIO International Convention

Asieris Pharmaceuticals Presented at the 2017 ChinaBio? Partnering Forum

TV Interview at Kick-off Meeting for the Pivotal Trial of Asieris’ Anti-Bladder Cancer Drug

Asieris to Present at 6th Annual Drug Repositioning, Repurposing and Rescue Conference

Asieris announced first patient in APL-1202 pivotal trial

Asieris announced initiation of APL-1202 pivotal clinical trial

Asieris Pharmaceuticals is invited to present at the China Bio Partnership Forum 2016

Scenes at the European Association of Urology (EAU) 2016 Congress

Interim results of China Phase II Clinical Trial of APL-1202 accepted for presentation

Asieris nominated as one of Jiangsu’s “Innovation and Entrepreneurship Top 60” SMEs